2011
DOI: 10.1016/j.parint.2011.06.024
|View full text |Cite
|
Sign up to set email alerts
|

Secnidazole for the treatment of giardiasis in naturally infected cats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
2
0
9

Year Published

2014
2014
2021
2021

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(13 citation statements)
references
References 27 publications
2
2
0
9
Order By: Relevance
“…The efficacy of secnidazole in lambs is comparable to what has been described in cats naturally infected with giardiasis, in which an oral single dose of 30 mg/kg resulted in 100 % efficacy, as no cysts were found in faeces after treatment (18). In the present study secnidazole treatment significantly reduced the cyst excretion calculated based on geometric mean by 99.98% on day 10 after the start of the treatment, resulting in a significant reduction (p<0.001) in cyst excretion in secnidazole treatment group.…”
Section: 98%supporting
confidence: 66%
See 3 more Smart Citations
“…The efficacy of secnidazole in lambs is comparable to what has been described in cats naturally infected with giardiasis, in which an oral single dose of 30 mg/kg resulted in 100 % efficacy, as no cysts were found in faeces after treatment (18). In the present study secnidazole treatment significantly reduced the cyst excretion calculated based on geometric mean by 99.98% on day 10 after the start of the treatment, resulting in a significant reduction (p<0.001) in cyst excretion in secnidazole treatment group.…”
Section: 98%supporting
confidence: 66%
“…Similar to surveys among humans, parasitological eradication rate of 100% was obtained after single-dose treatment with secnidazole in cats infected with G. duodenalis (18). Currently no drug is licensed or FDA approved for the treatment of giardiasis in ruminants.…”
Section: Materiales Y Métodossupporting
confidence: 52%
See 2 more Smart Citations
“…El secnidazol es utilizado actualmente por la industria farmacéutica para tratar la giardiasis, la amebiasis y la tricomoniasis en humanos; que tiene la principal ventaja de ser una dosis única. Actualmente, los investigadores están evaluando los resultados en mascotas y animales de producción debido a los resultados obtenidos con dosis únicas (9,10,11).…”
Section: Introductionunclassified